SCHEMBL10140691

SCHEMBL10140691

O=NCCCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28596029 0.90
SCHEMBL8902145 0.77
SCHEMBL6050015 0.76
SCHEMBL463669 0.76
Hydrochloric Acid SCHEMBL3108499 0.74
SCHEMBL214730 0.72
SCHEMBL14048657 0.72
SCHEMBL7269245 0.72
SCHEMBL6050020 0.72
SCHEMBL8310537 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021037204-A1 EARLY POST-EMERGENT HERBICIDAL ACTIVE COMPOSITION AND HERBICIDE 沈阳农业大学 2021-03-04 WO disclosed
EP-2521707-B1 BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2017-06-14 EP disclosed
US-20160304442-A1 ARYL NAPHTHYL METHANONE OXIME(S) AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-10-20 US disclosed
WO-2015029068-A1 ARYL NAPHTHYL METHANONE OXIME(S) AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-03-05 WO disclosed
US-20120142907-A1 MODIFIED MACROMOLECULES AND ASSOCIATED METHODS OF SYNTHESIS AND USE UNIVERSITY OF UTAH RESEARCH FOUNDATION 2012-06-07 US disclosed
US-7312218-B2 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors BRISTOL MYERS SQUIBB CO. (US) 2007-12-25 US disclosed
US-20070099922-A1 SULFONYLAMINOVALEROLACTAMS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS HAN WEI 2007-05-03 US disclosed
US-7169795-B2 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors BRISTOL MYERS SQUIBB COMPANY (US) 2007-01-30 US disclosed